Pregnancy represents a unique physiologic state characterized by dynamic vascular, immune, and hematologic adaptations that support maternal and fetal health. While these changes are often well tolerated, they may also unmask or exacerbate underlying systemic disease, contributing to maternal morbidity during pregnancy and the postpartum period. The retina, as a highly vascular and metabolically active tissue, offers a rare, noninvasive window into these systemic processes in vivo. This editorial perspective frames pregnancy as a physiologic “stress test,” highlighting how retinal findings can reflect broader maternal vascular, immune, and thrombotic dysfunction. Visual symptoms and retinal changes may serve as early indicators of hypertensive disorders of pregnancy, immune-mediated disease, and postpartum hypercoagulability. Despite this, ophthalmic manifestations are frequently underrecognized or attributed to benign physiologic changes, leading to missed opportunities for early diagnosis and intervention. By integrating ophthalmologic evaluation into maternal care, clinicians may improve risk stratification and facilitate earlier identification of high-risk conditions. This perspective underscores the importance of interdisciplinary collaboration and proposes a clinical framework in which retinal findings are recognized as meaningful markers of systemic disease rather than isolated ocular phenomena. Future research is needed to further define the prognostic value of retinal changes and to establish evidencebased guidelines for incorporating ophthalmology into maternal health care